Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non‐Hodgkin Lymphoma
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Xuanren Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Environment and Female Reproductive Health, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Resveratrol, Killer Cells, Natural, Lymphoma, Non-Hodgkin, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Shenzhen Natural Science Foundation (Basic Research Project, HaiYa Young Scientist Foundation of Shenzhen University General Hospital.
Abstract (Originalsprache)
Resveratrol (RSV) is a dietary polyphenolic compound with anticancer property. However, its clinical translation as an anticancer chemotherapeutic agent is hindered by multiple challenges. Chimeric antigen receptor (CAR) natural killer (NK) cell therapy has emerged as a promising immunotherapeutic strategy against refractory malignancies. The role of RSV in CAR NK cell therapy remains unexplored. This study pioneers the investigation of RSV's role in CAR NK immunotherapy. Specially, RSV preconditioning improved CAR NK cells’ resistance to oxidative stress, and augmented energetic metabolism in CAR NK cells. More importantly, the enhanced cytotoxicity against cancer cells of non‐Hodgkin lymphoma (NHL) and stronger cytokine secretions were observed in RSV‐treated anti‐CD19 CAR NK cells. In vivo tracking revealed RSV extended CAR NK tissue residency and enhanced therapeutic efficacy in NHL xenografts. RSV‐adjuvanted anti‐CD19 CAR NK therapy achieved an obvious reduction in intraperitoneal tumor burden and improvement in the mice survival. Our mechanistic investigation revealed that nuclear factor erythroid 2‐related factor 2 (NRF2) serves as a critical mediator in RSV‐induced functional augmentation of CAR NK cells. These findings established RSV as a potential polyphenol adjuvant capable of improving CAR NK therapy, providing a translatable strategy for polyphenols to overcome current limitations in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Environment and Female Reproductive Health, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
- Department of Hematology and Oncology, Shenzhen University General Hospital, Shenzhen, China.
- Department of Orthopaedics and Traumatology, Shenzhen University General Hospital, Shenzhen, China.
- BGI-Shenzhen, Shenzhen, China.
ORCID-Profile: Qingzheng Kang
Förderung
- Shenzhen Natural Science Foundation (Basic Research Project
- HaiYa Young Scientist Foundation of Shenzhen University General Hospital
Zitieren
APA
Shi, X., Wu, X., Yang, F., Hu, X., & Kang, Q. (2025). Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non‐Hodgkin Lymphoma. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70112
Vancouver
Shi X, Wu X, Yang F, Hu X, Kang Q. Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non‐Hodgkin Lymphoma. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70112
BibTeX
@article{Shi2025,
author = {Shi, Xuanren and Wu, Xiaoqing and Yang, Feng and Hu, Xiaofang and Kang, Qingzheng},
title = {Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non‐Hodgkin Lymphoma},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70112}
}
EUVIMED